On October 5th , 2012, Arkema successfully completed the issue of an additional €250 million tranche to its original bond due April 30th 2020, increasing its size to an aggregate amount of €480 million.
This new tranche, which has an annual yield slightly below 3%, enables Arkema to further benefit from current favourable market conditions. This transaction is fully in line with Arkema long-term financing policy of diversifying its financing resources and extending their maturity.
This issue has been jointly held by Crédit Agricole Corporate and Investment Bank, Lloyds Bank and Société Générale Corporate and Invesment Banking.
Arkema current financing resources also include a €700 million syndicated line of credit with a July 2016 maturity and a € 500 million bond with an October 2017 maturity.
Arkema is rated BBB with stable outlook by Standard & Poor’s, and Baa3 with positive outlook by Moody’s.
In view of the listing of the bonds on the Euronext Paris market place, Arkema has filed a prospectus which received visa n° 12-478 from the French capital market authority Autorité des marchés financiers dated 5th October 2012. Such prospectus is available in English version on Arkema Group’s website under the heading “Investor Relations” and on the website of the Autorité des marchés financiers (www.amf-france.org). Copies of the prospectus may be obtained free of charge at Société Générale, 32, rue du Champ de Tir, 44312 Nantes Cedex 3, France and at Arkema’s registered office (420, rue d’Estienne d’Orves – 92700 Colombes).
This press release is not an offer to buy or subscribe securities in the Unites States of America. The bonds have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered or sold within the United States or to U.S. persons. Accordingly, the bonds are being offered and sold only outside the United States in reliance on Regulation S under the Securities Act and are not being offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act).
A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generates annual revenue of €6.5 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.